Newly Established IT Infrastructure Company Investment Opportunity in Phnom Penh, Cambodia

Mid-stage series C established company in Cambodia and Vietnam which is currently under the process of legal registration respectively. We aspire to be at the forefront of Cambodia’s diabetes biotechnology and epidemiology research via rigorous literature review, medical ethics and scientific method utilisation.

Unlike traditional methods of insulin bio-manufacturing which requires up to 13 steps and proinsulin extra processing prior to cryogenic freezing, our technology only require 7 steps with no processing needed prior to freezing, greatly reducing costs of operation.

Company would co-operate with the Government of the Kingdom of Cambodia and local NGOs to produce and distribute insulin at moderate cost.

Company will have in-house designed and built drones that can carry ~500 ml biopharmaceutical load per run while, through internal electromagnetic mechanisms, maintain perfect condition for insulin harbouring and confer resistance against weather alterations.

Company has over US$100,000 net worth in physical assets and on-going digital application, bio-manufacturing and medical research operations.

Production & distribution of different concentrations of recombinant human generic insulin.

Business-to-door services.

Facility in Vietnam has 4 levels (lobby, work-space, bedrooms and a storage area). It is a fully equipped work-space.

Facility in Cambodia has 4 levels as well, equipped with machines and tools capable of biotechnological tasks, such as DNA sub-cloning, transformation, protein synthesis, diagnosis.

Another facility in Cambodia has 1 level, fitted with a studio (capable of editing and producing any sound files) and physics laboratory which specializes in drone development and 3D printing.